• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE TEX® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE TEX® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Device Problem Occlusion Within Device (1423)
Patient Problems Death (1802); Dyspnea (1816); Stenosis (2263); Aortic Dissection (2491)
Event Date 05/03/2011
Event Type  Injury  
Event Description
In a literature article it was reported that a (b)(6) male with a history of smoking and aortic valve replacement in 1995, presented with dyspnea on exertion which began in 2010.In (b)(6) 2011, the dyspnea progressed to appear during even low levels of exertion.Echocardiogram detected prosthetic aortic valve stenosis with an ejection fraction of 50%.The patient underwent aortic valve replacement in may 2011.During surgery, the patient had an aortic dissection with loss of both coronary ostia as a complication.Aortic valve replacement was performed and a bentall and bono procedure was implemented to reconstruct the aorta.The orifices of the coronary ostia were covered by the aortic tube and additional revascularization was performed by placing a saphenous vein graft to the right coronary artery and a 5 mm gore-tex® vascular graft to the left main (the cabrol procedure).After 48 hours of surgery, due to persisting hemodynamic instability, the patient was taken to the cath lab to check the status of both coronary grafts.It was stated that an angiogram showed a diffuse stenosis of the gore-tex® vascular graft to the left main starting at the site of the coronary aorta-anastomosis with impaired distal flow around the left coronary system.An emergency percutaneous intervention to rescue the cabrol graft was successfully performed.The patient was hemodynamically stable after the procedure and was extubated two weeks post procedure.Unfortunately the patient expired 2 months after the procedure due to an infectious lung disease.
 
Manufacturer Narrative
History of smoking, aortic valve replacement in 1995, dyspnea on exertion which began in 2010.No lot number information was supplied; therefore, no review of the manufacturing paperwork could be performed.The device remained implanted; consequently, a direct product analysis was not possible.Without additional information it is impossible to further investigate this event.
 
Manufacturer Narrative
Additional information: literature citation: gonzález j, peña duque m, larraga m.Early stenosis in a gore-tex graft connected to the left main: an emergency transradial angioplasty for a complication in a cabrol procedure.J invasive cardol 2012, 24(10):539-542.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE TEX® VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
sandra whicker
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key4419112
MDR Text Key5278623
Report Number2017233-2015-00021
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeMX
PMA/PMN Number
K802095
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/20/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/14/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received02/20/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
-
-